Acadia Pharmaceuticals Inc. · NASDAQ:ACAD

Kihara James sold 11,421 Acadia Pharmaceuticals Inc. shares (Form 4)

Traded Jun 26, 2026 · Filed Jun 29, 2026

On Jun 26, 2026, Kihara James (PRINCIPAL ACCOUNTING OFFICER) sold 11,421 Acadia Pharmaceuticals Inc. shares at US$26.08 for US$298K under a trading plan, leaving 13,088 shares. Filed Jun 29, 2026 (Form 4).

Sold
11,421 shares
Price
US$26.08
Value
US$298K
Holding after
13,088 shares
Trading plan
Yes (Made under a plan set in advance)
Role
PRINCIPAL ACCOUNTING OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 26, 2026Common StockSale11,421US$26.0813,088Direct

Source

View original at SEC

Related